PMID- 31016876 OWN - NLM STAT- MEDLINE DCOM- 20210809 LR - 20210809 IS - 1552-4981 (Electronic) IS - 1552-4973 (Print) IS - 1552-4973 (Linking) VI - 108 IP - 2 DP - 2020 Feb TI - Nanofibrous antibiotic-eluting matrices: Biocompatibility studies in a rat model. PG - 306-315 LID - 10.1002/jbm.b.34389 [doi] AB - This study evaluated the biocompatibility of degradable polydioxanone (PDS) electrospun drug delivery systems (hereafter referred as matrices) containing metronidazole (MET) or ciprofloxacin (CIP) after subcutaneous implantation in rats. Sixty adult male rats were randomized into six groups: SHAM (sham surgery); PDS (antibiotic-free matrix); 1MET (one 25 wt% MET matrix); 1CIP (one 25 wt% CIP matrix); 2MET (two 25 wt% MET matrices); and 2CIP (two 25 wt% CIP matrices). At 3 and 30 days, animals were assessed for inflammatory cell response (ICR), collagen fibers degradation, and oxidative profile (reactive oxygen species [ROS]; lipid peroxidation [LP]; and protein carbonyl [PC]). At 3 days, percentages of no/discrete ICR were 100, 93.3, 86.7, 76.7, 50, and 66.6 for SHAM, PDS, 1MET, 1CIP, 2MET, and 2CIP, respectively. At 30 days, percentages of no/discrete ICR were 100% for SHAM, PDS, 1MET, and 1CIP and 93.3% for 2MET and 2CIP. Between 3 and 30 days, SHAM, 1CIP, and 2CIP produced collagen, while 1MET and 2MET were unchanged. At 30 days, the collagen fiber means percentages for SHAM, PDS, 1MET, 1CIP, 2MET, and 2CIP were 63.7, 60.7, 56.6, 62.6, 51.8, and 61.7, respectively. Antibiotic-eluting matrices showed similar or better oxidative behavior when compared to PDS, except for CIP-eluting matrices, which showed higher levels of PC compared to SHAM or PDS at 30 days. Collectively, our findings indicate that antibiotic-eluting matrices may be an attractive biocompatible drug delivery system to fight periodontopathogens. (c) 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part B, 2019. CI - (c) 2019 Wiley Periodicals, Inc. FAU - Passos, Patricia C AU - Passos PC AD - Post-Graduate Program in Oral Science (Periodontology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Moro, Juliana AU - Moro J AD - Post-Graduate Program in Oral Science (Pathology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Barcelos, Raquel Cristine Silva AU - Barcelos RCS AD - Post-Graduate Program in Oral Science (Pathology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Da Rosa, Higor Z AU - Da Rosa HZ AD - Post-Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Vey, Luciana T AU - Vey LT AD - Post-Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Burguer, Marilise Escobar AU - Burguer ME AD - Post-Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Maciel, Roberto M AU - Maciel RM AD - Post-Graduate Program in Oral Science (Pathology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Danesi, Cristiane C AU - Danesi CC AD - Post-Graduate Program in Oral Science (Pathology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. FAU - Edwards, Paul C AU - Edwards PC AD - Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Indianapolis, Indiana. FAU - Bottino, Marco C AU - Bottino MC AUID- ORCID: 0000-0001-8740-2464 AD - Department of Cariology, Restorative Sciences, and Endodontics, University of Michigan School of Dentistry, Ann Arbor, Michigan. FAU - Kantorski, Karla Z AU - Kantorski KZ AD - Post-Graduate Program in Oral Science (Periodontology Unit), School of Dentistry, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil. LA - eng GR - K08 DE023552/DE/NIDCR NIH HHS/United States GR - R01 DE026578/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20190423 PL - United States TA - J Biomed Mater Res B Appl Biomater JT - Journal of biomedical materials research. Part B, Applied biomaterials JID - 101234238 RN - 0 (Anti-Bacterial Agents) RN - 0 (Biocompatible Materials) RN - 0 (Nanocapsules) RN - 0 (Reactive Oxygen Species) RN - 140QMO216E (Metronidazole) RN - 31621-87-1 (Polydioxanone) RN - 5E8K9I0O4U (Ciprofloxacin) SB - IM MH - Animals MH - Anti-Bacterial Agents/*chemistry/pharmacology MH - Biocompatible Materials/*chemistry MH - Ciprofloxacin/*chemistry/pharmacology MH - Drug Liberation MH - Humans MH - Male MH - Metronidazole/*chemistry/pharmacology MH - Nanocapsules/*chemistry MH - Nanofibers/*chemistry MH - Oxidation-Reduction MH - Polydioxanone/*chemistry MH - Prosthesis Implantation MH - Rats MH - Reactive Oxygen Species/metabolism MH - Time Factors MH - Tissue Engineering MH - Tissue Scaffolds PMC - PMC6812584 MID - NIHMS1024282 OTO - NOTNLM OT - biomaterials OT - drug delivery OT - electrospinning OT - nanofibers OT - periodontitis EDAT- 2019/04/25 06:00 MHDA- 2021/08/10 06:00 PMCR- 2021/02/01 CRDT- 2019/04/25 06:00 PHST- 2019/01/03 00:00 [received] PHST- 2019/03/18 00:00 [revised] PHST- 2019/04/04 00:00 [accepted] PHST- 2019/04/25 06:00 [pubmed] PHST- 2021/08/10 06:00 [medline] PHST- 2019/04/25 06:00 [entrez] PHST- 2021/02/01 00:00 [pmc-release] AID - 10.1002/jbm.b.34389 [doi] PST - ppublish SO - J Biomed Mater Res B Appl Biomater. 2020 Feb;108(2):306-315. doi: 10.1002/jbm.b.34389. Epub 2019 Apr 23.